Editas Medicine
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell EDIT and other ETFs, options, and stocks.About EDIT
Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9).
CEOGilmore O’Neill
CEOGilmore O’Neill
Employees246
Employees246
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2013
Founded2013
Employees246
Employees246
EDIT Key Statistics
Market cap241.09M
Market cap241.09M
Price-Earnings ratio-0.95
Price-Earnings ratio-0.95
Dividend yield—
Dividend yield—
Average volume3.92M
Average volume3.92M
High today$3.11
High today$3.11
Low today$2.80
Low today$2.80
Open price$3.03
Open price$3.03
Volume2.25M
Volume2.25M
52 Week high$6.05
52 Week high$6.05
52 Week low$0.9101
52 Week low$0.9101
Analyst ratings
50%
of 14 ratingsBuy
35.7%
Hold
50%
Sell
14.3%
People also own
Based on the portfolios of people who own EDIT. This list is generated using Robinhood data, and it’s not a recommendation.